William Woods
Stock Analyst at B. Riley Securities
(1.34)
# 3,445
Out of 5,182 analysts
14
Total ratings
33.33%
Success rate
-6.74%
Average return
Main Sectors:
Stocks Rated by William Woods
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRMD KORU Medical Systems | Maintains: Buy | $7 → $8 | $4.19 | +90.93% | 2 | Mar 13, 2026 | |
| ALT Altimmune | Maintains: Buy | $18 → $13 | $3.37 | +285.76% | 1 | Mar 6, 2026 | |
| PALI Palisade Bio | Initiates: Buy | $7 | $1.87 | +274.33% | 1 | Jan 9, 2026 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $560 → $670 | $519.75 | +28.91% | 1 | Dec 11, 2025 | |
| OKYO OKYO Pharma | Initiates: Buy | $5 | $1.59 | +214.47% | 1 | Dec 8, 2025 | |
| CGTX Cognition Therapeutics | Reiterates: Buy | $2 → $3 | $0.88 | +240.83% | 1 | Nov 21, 2025 | |
| LFMD LifeMD | Maintains: Buy | $12 → $10 | $3.47 | +188.18% | 3 | Nov 18, 2025 | |
| IMUX Immunic | Reiterates: Buy | $6 → $5 | $1.19 | +320.17% | 3 | May 23, 2025 | |
| VERU Veru Inc. | Initiates: Buy | $50 | $2.56 | +1,855.42% | 1 | May 14, 2024 |
KORU Medical Systems
Mar 13, 2026
Maintains: Buy
Price Target: $7 → $8
Current: $4.19
Upside: +90.93%
Altimmune
Mar 6, 2026
Maintains: Buy
Price Target: $18 → $13
Current: $3.37
Upside: +285.76%
Palisade Bio
Jan 9, 2026
Initiates: Buy
Price Target: $7
Current: $1.87
Upside: +274.33%
Madrigal Pharmaceuticals
Dec 11, 2025
Maintains: Buy
Price Target: $560 → $670
Current: $519.75
Upside: +28.91%
OKYO Pharma
Dec 8, 2025
Initiates: Buy
Price Target: $5
Current: $1.59
Upside: +214.47%
Cognition Therapeutics
Nov 21, 2025
Reiterates: Buy
Price Target: $2 → $3
Current: $0.88
Upside: +240.83%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $3.47
Upside: +188.18%
Immunic
May 23, 2025
Reiterates: Buy
Price Target: $6 → $5
Current: $1.19
Upside: +320.17%
Veru Inc.
May 14, 2024
Initiates: Buy
Price Target: $50
Current: $2.56
Upside: +1,855.42%